U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668414) titled 'A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide' on June 19.
Brief Summary: The purpose of this study is to find out if zenagamtide is safe and effective for treating participants who have excess body weight compared to treatment with semaglutide.
Study Start Date: Sept. 22, 2026
Study Type: INTERVENTIONAL
Condition:
Overweight
Obesity
Intervention:
DRUG: Zenagamtide
Zenagamtide will be administered subcutaneously using pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.
DRUG: Semaglutide
Semaglutide will be...